Work Aggravated Asthma in the UK v0.1

  • Research type

    Research Study

  • Full title

    Work aggravated asthma in the UK

  • IRAS ID

    155281

  • Contact name

    Lisa Bradshaw

  • Contact email

    lisa.bradshaw@hsl.gsi.gov.uk

  • Sponsor organisation

    Health and Safety Executive (Corporate Science Unit)

  • Duration of Study in the UK

    1 years, 6 months, 2 days

  • Research summary

    Work aggravated asthma (WAA) is defined as “pre-existing or concurrent asthma that is worsened by workplace conditions” (Henneberger, 2011). Concurrent asthma in this context is defined as “asthma with onset while employed in the worksite of interest, but not due to exposures in that worksite”. This would include workers previously diagnosed with occupational asthma who have moved to a new workplace where the current irritant exposures may aggravate their asthma control.

    In 2013, a HSL research report; ‘Work Aggravated Asthma a Review of Reviews’ (PH01626) identified that WAA is a common occurrence, with large numbers of workers with coincident or pre-existing asthma developing significant worsening or aggravation of their symptoms due to workplace exposures. Prevalence estimates varied according to the populations studied. Henneberger (2011) reported a median prevalence estimate of 21.5%, and a range represented by the 12 included studies of between 13% to 58%. However, no UK prevalence estimates were identified. There is a paucity of literature on the socio-economic impact of WAA. However, the available evidence suggests that WAA is associated with a significant socioeconomic impact.

    The first phase of this study will collect data to estimate the prevalence of WAA in the UK from the Primary Care Research Network (PCRN) and a Third Sector Institution. A self-administered questionnaire will be used to collect data regarding work aggravated asthma, prevelance, work limitations and health-related quality of life.
    To describe the socio-economic impact of work aggravated asthma in the UK, semi-structured face to face interviews will be used to collect qualitative data in a second Phase. The interviews will be recorded and will enquire about current health issues, work, social and financial impact of WAA.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    14/SC/1296

  • Date of REC Opinion

    19 Sep 2014

  • REC opinion

    Favourable Opinion